CAMBRIDGE, Mass., April 02, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
Seven presentations by AC Immune and its partners at AAT-AD/PD™New data on early-stage TDP-43 and alpha-synuclein therapeutic and diagnostic candidates A […]
NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) — ArTara Therapeutics, Inc. (Nasdaq: TARA), a development-stage clinical biopharmaceutical company developing treatments […]